enhanced immune responses of a hepatitis c virus core dna vaccine by co-inoculating interleukin-12 expressing vector in mice
نویسندگان
چکیده
background: hepatitis c (hcv) is a worldwide problem without an effective vaccine with more than 170 million chronically infected people worldwide. dna vaccines expressing antigenic portions of the virus with adjutants have recently been developed as a novel vaccination technology. objectives: in the present study, a dna vaccine expressing hcv core protein was developed with il12 as a genetic adjuvant and different aspects of cell immune responses due to this vaccine were evaluated in an animal model of the infection. material and methods: hcv core gene was inserted into pcdna3. 1(-) eukaryotic expression vector and the recombinant plasmid was transformed into dh5α competent cells and a large scale dna vaccine was prepared. the expression of the vector was verified in cho cell line. female c57bl/6 mice were immunized 3 times with 90 ng doses of the dna vaccine on days 0, 14 and 28. two weeks after the last immunization, the immune responses against hcv core antigen were assessed by lymphocyte proliferation, ctl cytotoxicity and cytokines secretion assays. results: the results showed that the co-administration of il12, as a genetic adjuvant, increased the ability of hcv core dna vaccine to enhance cytolytic t lymphocyte activity, lymphocyte proliferation and shifting of the immune response toward a t helper (th1) pattern and altogether improved the protective immunity. conclusion: this study demonstrated that intramuscular injection of hcv core dna vaccine with a genetic adjuvant induced significant cellular immune responses in c57bl/6 mice.
منابع مشابه
Enhanced Immune Responses of a Hepatitis C Virus core DNA Vaccine by co-Inoculating Interleukin-12 Expressing Vector in Mice
Background: Hepatitis C (HCV) is a worldwide problem without an effective vaccine with more than 170 million chronically infected people worldwide. DNA vaccines expressing antigenic portions of the virus with adjutants have recently been developed as a novel vaccination technology. Objectives: In the present study, a DNA vaccine expressing HCV core protein was developed with IL12 as a genetic a...
متن کاملImmunogenicity Evaluation of a DNA Vaccine Expressing the Hepatitis C Virus Non-Structural Protein 2 Gene in C57BL/6 Mice
Backgrounds: Most of the hepatitis C virus (HCV) infections elicit poor immune responses and 75% to 85% of cases become chronic therefore, the development of an effective vaccine against HCV is of paramount importance. In this study, we aimed to evaluate co-administration of HCV non-Structural Protein 2 and IL-12 DNA vaccines in C57BL/6 mice. Methods: A plasmid encoding full-length HCV NS2 prot...
متن کاملImmune Responses against a New HIV-1 p24-gp41/pCAGGS-IL-12 DNA Vaccine in Balb/c Mice
Background: Development of an effective vaccine is highly needed in order to restrict the AIDS pandemic. DNA vaccines initiate both arms of immunity without the potential of causing disease. HIV-1 p24 and gp41 (gag and env) proteins play important roles in viral pathogenesis and are effective candidates for immune induction and vaccine design. Objective: In this study, new DNA vaccine candidate...
متن کاملubiquitin conjugation of hepatitis b virus core antigen dna vaccine leads to enhanced cell-mediated immune response in balb/c mice
متن کامل
Assessment of humoral immune response of a Cytomegalovirus DNA-vaccine candidate in BALB/c mice
Introduction: Glycoprotein B (gB) is the major antigen for induction of humoral responses against human cytomegalovirus (HCMV) making it an attractive candidate for immune prophylaxis. In the present study, the humoral immune response of BALB/c mice to a truncated HCMV gB protein fused with GFP was evaluated. Methods: The truncated gB coding sequence was synthesized and cloned in pEGFPN1 eukary...
متن کاملimmune responses against a new hiv-1 p24-gp41/pcaggs-il-12 dna vaccine in balb/c mice
background: development of an effective vaccine is highly needed in order to restrict the aids pandemic. dna vaccines initiate both arms of immunity without the potential of causing disease. hiv-1 p24 and gp41 (gag and env) proteins play important roles in viral pathogenesis and are effective candidates for immune induction and vaccine design. objective: in this study, new dna vaccine candidate...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
vaccine researchجلد ۱، شماره ۲، صفحات ۲۹-۳۳
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023